Application and mechanisms of Sanhua Decoction in the treatment of cerebral ischemia-reperfusion injury.

Sanhua Decoction, a traditional Chinese medicinal formulation, shows potential in treating cerebral ischemia-reperfusion injury. It acts through antioxidant, anti-inflammatory, and neurotransmitter regulatory pathways to protect nerve cells and reduce cerebral edema. Studying its mechanisms can improve understanding and future clinical application.

Wang YK et al (2024).

World J Clin Cases.

DOI:

10.12998/wjcc.v12.i4.688

PubMed:

38322692

In-silico molecular docking and molecular dynamic simulation of γ-elemene and caryophyllene identified from the essential oil of Kaempferia galanga L. against biofilm forming proteins, CrtM and SarA of Staphylococcus aureus.

Sharma V et al (2024).

J Biomol Struct Dyn.

DOI:

10.1080/07391102.2024.2310773

PubMed:

38321959

Dendrobine: A neuroprotective Sesquiterpenic Alkaloid for the Prevention and Treatment of Diseases: A Review.

Dendrobine, a compound extracted from Dendrobium nobile Lindl, has neuroprotective effects and potential in treating cognitive disorders, anxiety, depression, Alzheimer's disease, Parkinson's disease, and inflammation. It activates neuro synapses and neurotransmission pathways.

Bhardwaj K et al (2024).

Mini Rev Med Chem.

DOI:

10.2174/0113895575274314240125105120

PubMed:

38321903

Traditional Uses, Phytochemistry, and Pharmacological Activities of Coleus amboinicus: A Comprehensive Review.

Paul K et al (2024).

Curr Pharm Des.

DOI:

10.2174/0113816128283267240130062600

PubMed:

38321896

Evaluation of the inhibitory potential of bioactive compounds against SARS-CoV-2 by in silico approach.

Researchers investigated the antiviral potential of bioactive compounds from medicinal plants to treat COVID-19. Compounds from Sphaeranthus indicus, Lantana camara, and Nelumbo nucifera showed inhibitory effects against SARS-CoV-2 in molecular docking studies. Consider these natural compounds for potential treatment.

Rani JMS et al (2024).

J Mol Model.

DOI:

10.1007/s00894-024-05858-8

PubMed:

38321299

A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19.

Researchers conducted a study on medicinal plants for COVID-19 treatment and found promising results. Medicinal plants have benefits like better tolerability, compatibility with the human body, and fewer side effects, making them important for healthcare in both developing and developed countries.

Balan AK et al (2024).

J Ayurveda Integr Med.

DOI:

10.1016/j.jaim.2023.100860

PubMed:

38320447

Anti-herbivory defences delivered by Epichloë fungal endophytes: a quantitative review of alkaloid concentration variation among hosts and plant parts.

Realini FM et al (2024).

Ann Bot.

DOI:

10.1093/aob/mcae014

PubMed:

38320313

Evolution and diversification of carboxylesterase-like [4+2] cyclases in aspidosperma and iboga alkaloid biosynthesis.

DeMars MD 2nd and O'Connor SE (2024).

Proc Natl Acad Sci U S A.

DOI:

10.1073/pnas.2318586121

PubMed:

38319969